Ron Cohen
2006
In 2006, Ron Cohen earned a total compensation of $1.4M as President and Chief Executive Officer at Acorda Therapeutics.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $181,968 |
| Salary | $370,000 |
| Stock Awards | $634,254 |
| Total | $1,411,222 |
Cohen received $634.3K in stock awards, accounting for 45% of the total pay in 2006.
Cohen also received $225K in bonus, $182K in option awards and $370K in salary.
Rankings
In 2006, Ron Cohen's compensation ranked 2,368th out of 7,022 executives tracked by ExecPay. In other words, Cohen earned more than 66.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,368 out of 7,022 | 66th |
Division Manufacturing | 727 out of 2,413 | 70th |
Major group Chemicals And Allied Products | 142 out of 673 | 79th |
Industry group Drugs | 83 out of 518 | 84th |
Industry Biological Products, Except Diagnostic Substances | 12 out of 112 | 89th |
Source: SEC filing on April 30, 2009.
Cohen's colleagues
We found four more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2006.
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019